Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2012
08/09/2012US20120202803 N-[3-(5-amino-3,3a,7,7a-tetrahydro-1h-2,4-dioxa-6-aza-inden-7-yl)-phenyl]-amides as bace1 and/or bace2 inhibitors
08/09/2012US20120202802 Spirocyclic compounds as modulators of chemokine receptor activity
08/09/2012US20120202797 SUBSTITUTED [(5H-PYRROLO[2,1-c][1,4]BENZODIAZEPIN-11-YL)PIPERAZIN-1-YL]-2,2-DIMETHYLPROPANOIC ACID COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS
08/09/2012US20120202795 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp)
08/09/2012US20120202791 Tricyclic and Tetracyclic Systems with Activity on the Central Nervous and Vascular Systems
08/09/2012US20120202790 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
08/09/2012US20120202788 Azabenzothiazole compounds, compositions and methods of use
08/09/2012US20120202787 Novel Heteroaryl Imidazoles And Heteroaryl Triazoles As Gamma-Secretase Modulators
08/09/2012US20120202785 Heterocyclic compounds and methods of use
08/09/2012US20120202783 Fused heterocyclic compounds as orexin receptor modulators
08/09/2012US20120202781 Indane derivatives
08/09/2012US20120202774 Acyloxy- and phosphoryloxy-butadiene-fe(co)3 complexes as enzyme-triggered co-releasing molecules
08/09/2012US20120202769 Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof
08/09/2012US20120202764 Low molecular weight pharmacological activity modulators
08/09/2012US20120202758 Core 2glcnac-t inhibitors
08/09/2012US20120202756 Use of prodrugs to avoid gi mediated adverse events
08/09/2012US20120202746 Daptomycin for multiple sclerosis
08/09/2012US20120202745 Adult cerebellum-derived neural stem cells and compositions and methods for producing oligodendrocytes
08/09/2012US20120202744 Dual antagonism of endothelin type a and bradykinin b1 receptors for treating pain and preventing cartilage degradation
08/09/2012US20120201908 Method of treating bipolar disorder or depression using an antiestrogen
08/09/2012US20120201889 Modified and immediate release formulations of memantine
08/09/2012US20120201888 Pharmaceutical Compositions
08/09/2012US20120201876 Method of managing hypercortisolemia, headache disorders, neuropathic pain and related disorders
08/09/2012US20120201872 Liposomes comprising a calcium phosphate-containing precipitate
08/09/2012US20120201844 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
08/09/2012US20120201842 Prevention and treatment of synucleinopathic and amyloidogenic disease
08/09/2012US20120201831 Human antibodies that bind human il-12 and methods for producing
08/09/2012US20120201818 Treatment of multiple sclerosis
08/09/2012US20120201804 Tissue kallikrein for the treatment of schizophrenia and bipolar disorder
08/09/2012US20120201791 Methods of treating diseases or conditions using mesenchymal stem cells
08/09/2012US20120201789 Generation of choroid plexus epithelial cells from human embryonic stem cells
08/09/2012US20120201788 Methods and compositions for cell therapy
08/09/2012US20120201787 Treatment of spinal cord injury and traumatic brain injury using amnion derived adherent cells
08/09/2012US20120201781 Treatment of osteoarthritis and pain
08/09/2012US20120201780 T. cruzi-derived neurotrophic agents and methods of use therefor
08/09/2012US20120201761 Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent
08/09/2012US20120201757 Mutant low-density lipoprotein receptor related protein with increased binding to alzheimer amyloid-beta peptide
08/09/2012US20120201756 Plasma kallikrein binding proteins
08/09/2012US20120201754 Phosphodiesterase 1-targeting tracers and methods
08/09/2012US20120201749 NP-1 Antagonists and Their Therapeutic Use
08/09/2012US20120201748 Coacervate having an ionic polymer mixed with the adhesive protein of a mussel or of a species of the variome thereof
08/09/2012US20120201747 System and Method for Diagnosis and Treatment
08/09/2012US20120199516 Method for treating multiple sclerosis
08/09/2012CA2828570A1 Tetrahydroisoquinoline derivative
08/09/2012CA2826286A1 Treatment of tauopathies
08/09/2012CA2826217A1 Transdermal patch
08/09/2012CA2826200A1 Caspase-2 inhibitors
08/09/2012CA2826180A1 Dosage regimen, medication dispensing package and uses thereof for the treatment of major depressive disorder
08/09/2012CA2826003A1 Patch preparation
08/09/2012CA2825641A1 Use of icam-1 for prevention or treatment of neurological diseases
08/09/2012CA2825204A1 Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
08/09/2012CA2824929A1 (1,2,4)triazolo[4,3-a]quinoxaline derivatives as inhibitors of phosphodiesterases
08/09/2012CA2824735A1 Prophylactic or therapeutic agent for a peripheral nerve disorder induced by anti-cancer agents
08/09/2012CA2823870A1 Inhibitors of the interaction of the sigma-1 receptor with herg for use in the treatment of cancer
08/09/2012CA2817841A1 1,4 oxazines as bace1 and/or bace2 inhibitors
08/08/2012EP2484675A1 Novel phenylpyridine derivative and medicinal agent comprising same
08/08/2012EP2484664A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same
08/08/2012EP2484381A1 Composition for a treatment of demyelinating diseases and paralysis by administration of remyelinating agents
08/08/2012EP2484363A1 (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-5-methylthiophene-2-carboxamide
08/08/2012EP2484362A2 Use of gymnodimine, analogues and derviatives for the treatment and/or prevention of neurodegenerative diseases associated with tau and b-amyloid
08/08/2012EP2484358A1 Agent for inhibiting decrease of visceral fat in patient with parkinson's disease
08/08/2012EP2483275A1 HETEROCYCLIC-FUSED PYRAZOLO[4,3-c]PYRIDIN-3-ONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS
08/08/2012EP2483271A1 Pyrazoline dione derivatives as nadph oxidase inhibitors
08/08/2012EP2483270A1 Indazole derivatives and their use for blockading voltage dependent sodium channels
08/08/2012EP2483257A2 2,3,4-benzothiadiazepine-2,2-dioxide derivatives
08/08/2012EP2483255A1 Oxazine derivatives and their use in the treatment of neurological disorders
08/08/2012EP2483254A1 Novel compounds
08/08/2012EP2483237A1 Amide derivatives of valproic acid and uses thereof
08/08/2012EP2482838A1 Use of botulinum neurotoxin to treat substance addictions
08/08/2012EP2482835A1 Therapy and prevention of problem drinking
08/08/2012EP2482827A1 Antioxidants for use in therapy
08/08/2012EP2279184B1 Indole modulators of the alpha-7 nicotinic acetylcholine receptor
08/08/2012EP2279183B1 Indoles as modulators of nicoticic acetylcholine receptor subtype alpha-7
08/08/2012EP2268657B1 Histidine related compounds for identifying and blocking amyloid beta ion channels
08/08/2012EP2268632B1 Tertiary amine derivatives as phosphodiesterase-4 inhibitors
08/08/2012EP2205253B1 Composition and method inhibiting inflammation
08/08/2012EP2190447B1 His-Pro-Gly-Ser-Arg-lle-Val-Leu-Ser-Leu-Asp-Val-Pro-lle-Gly-Leu-Leu-Gln-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Ala-Arg-Ala-Ala-Arg-Glu-Gln-Ala-Thr-Thr-Asn-Ala-Arg-ile-Leu-Ala-Arg-Val-NH2 for use in anti-angiogenic therapy
08/08/2012EP2187901B1 Neuropeptide El optionally combined with ACTH (7-38) for use in anti-angiogenic therapy
08/08/2012EP2170297B1 Duloxetine formulation
08/08/2012EP2114158B1 3-substituted-[1,2,3]benzotriazinone compounds for enhancing glutamatergic synaptic responses
08/08/2012EP2066680B1 Triphenylphosphonium thionitrite nitric oxide donors
08/08/2012EP1996554B1 Sigma receptor inhibitors
08/08/2012EP1966158B1 Substituted cinnoline derivatives as gabaa-receptor modulators and method for their synthesis
08/08/2012EP1868614B1 Dosage regimen for the treatment of a traumatic brain injury with progesterone
08/08/2012EP1727545B1 Use of n-piperidine derivatives for the treatment of neurodegenerative pathologies
08/08/2012EP1601674B1 Hydroxyalkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
08/08/2012EP1491212B1 Remedy for sleep disturbance
08/08/2012EP1458399B1 Pregnane steroids for use in the treatment of cns disorders
08/08/2012EP1169038B1 Cyclic protein tyrosine kinase inhibitors
08/08/2012EP1054664B1 Method for modulating macrophage activation
08/08/2012EP0837938B1 Use of mp52 or mp121 for treating and preventing diseases of the nervous system
08/08/2012CN202366203U Wetting agent type ointment patch
08/08/2012CN1439375B Dehydroepiandrosterone treating use and transfer system
08/08/2012CN102630167A Treatment of neurological conditions
08/08/2012CN102630162A 4-methylpyrazole formulations
08/08/2012CN102627676A C-aryl glucoside sglt2 inhibitors and method
08/08/2012CN102627640A Heterobicyclic compounds useful as p38 kinase inhibiting agents
08/08/2012CN102627620A One type of benzofuran derivatives and medical application thereof
08/08/2012CN102627611A Polymorphic form of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one
08/08/2012CN102627609A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors
1 ... 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 ... 1833